2026 USCHA Pathways (Preliminary)

Explore 2026 USCHA Pathways, your guide to navigating this year’s Institutes, Workshops, and iPosters organized by topics and audiences that matter most to you. Whether you’re focused on one area of interest or several, each Pathway highlights sessions aligned to that theme, and since many sessions speak to multiple populations and topics, you may see a few favorites appear more than once.

Filter conference sessions by Pathway, Track, or keyword. Results update on this page when JavaScript is available.

Crosscutting Topics

Total: 6 sessions

  • Institute: 1
  • iPosters: 2
  • Workshops: 3
Showing 6 of 316 Sessions
Updating session results.

Track 7

Changing the Conversation: From Sexual History to Sexual Health

Presenter:
Erica A. Bostick, MD, Physician, Associate Professor of Pediatrics and Medicine, University of Rochester, Rochester, NY; Daniela DiMarco, MD, MPH, University of Rochester, Rochester, NY; Emily Ryan-Kaltenbach, Rochester, NY; Megan Honeck, Rochester, NY; Jonathan Jordan, Rochester, NY

Workshops Session 6

Saturday, September 19 · 10:15 am – 11:45 am

Location: Redondo – Concourse Level/4th Floor

Successful HIV prevention goes beyond testing, beginning with a sexual health assessment classically termed the “sexual history.” By utilizing a sex-positive and trauma-informed lens, sexual health assessments can be reframed as conversations that help dismantle stigma and open doors to treating the whole person – mind, body, and community. By attending this institute, learners will gain knowledge and skills to conduct effective sexual health assessments that encourage open sexual health conversations and break down barriers to health promotion.

Learning Objectives:
1. Conduct a sexual health assessment through a sex-positive, trauma-informed lens. 2. Adapt sexual health conversational language to be without judgement or assumptions about behaviors, effectively assessing an individual’s priorities for their own sexual health. 3. Integrate health literacy best practices throughout sexual health conversations. 4. Identify opportunities to implement sexual health harm-reduction methods that prioritize client needs.

Track 7

Community HERO Treatment  Survey: insights into rapid antiretroviral therapy initiation patterns and perceptions across a global population of PWH

Presenter:
Cassandra Esperant, PharmD, AAHIVP

iPoster Session 3

Saturday, September 19 · 2:30 pm – 3:00 am

Location: 4th Floor iPoster Desk

Treatment Survey: insights into rapid antiretroviral therapy initiation patterns and perceptions across a global population of PWH

Track 7

Does Phone Call Appointment Scheduling Impact Anal Cancer Screening Rates in Biological Males Living with HIV?

Presenter:
Nichole Padron DNP CRNP FNP-bc

Organizer:
St. Luke's University Health Network

Track 7

Heart Health in HIV: Moving Beyond REPRIEVE (listed ins Submittable as: Keeping with the Rhythm: Practical Approaches to Cardiovascular Prevention Guidelines in HIV Primary Care)

Presenter:
Douglas Meardon, MD, AAHIVS; Jack D. Ledford, Pharm.D., BCPS, BCACP, AAHIVP, Charlotte, NC

Workshops Session 5

Saturday, September 19 · 8:30 am – 10:00 am

Location: Redondo – Concourse Level/4th Floor

This interactive workshop focuses on the assessment and management of cardiovascular disease (CVD) risk in people living with HIV (PWLH). Participants will explore the epidemiology and pathophysiologic mechanisms underlying elevated CVD risk in this population, review both traditional and HIV-specific risk factors (viral load, CD4 count, antiretroviral therapy), and apply guideline-driven strategies, including 2026 ACC/AHA and DHHS recommendations, plus newer tools such as PREVENT-ASCVD and emerging biomarkers (Lipoprotein(a), ApoB, CAC, hsCRP).

Learning Objectives:
1. Describe the epidemiology and pathophysiologic mechanisms contributing to elevated cardiovascular disease risk in PWLH. 2. Identify traditional and HIV-specific cardiovascular risk factors, including antiretroviral therapy-related effects. 3. Apply current ACC/AHA and DHHS guideline recommendations to cardiovascular risk stratification, using validated risk calculators. 4. Describe emerging cardiovascular risk markers to refine risk assessment for PWLH. 5. Select appropriate lipid-lowering and non-statin therapies for primary and secondary prevention of cardiovascular disease in people with HIV.

Track 7

HIV PrEP and Treatment Injections and Clinic Implementation 101

Presenter:
Rupa Patel, MD | Whitman-Walker Health | Washington, DC; Carloyn Chu, MD | NCCC, UCSF | San Francisco, CA; Christina Madison, PharmD | [Organization not specified] | [City/State not; specified]; Chris Bositis, MD | NCCC, UCSF | San Francisco, CA; Anu Hazra, MD | Howard Brown Health / University of Chicago | Chicago,; IL

Institutes Session 2

Friday, September 18 · 8:00 am – 11:00 am

Location: Laguna – Concourse Level/4th Floor

The audience will review/practice LA ARV injection technique using a demonstration kitfor cabotegravir and lenacapavir. Attendees will review injection sites, pre and post-injection education, and publicly-available resources for future hands-on trainings. Experienced faculty will answer questions, observe injection technique, and discuss injection methods. Attendees will discuss real-world examples of clinic implementation protocols for LA ARV injections for HIV treatment and prevention. Clinic protocol details will include workflows for insurance coverage and medication acquisition, scheduling, appointment reminders, medication windows, communication with health teams, referral processes, collaborations with community organizations, aspects of patient messaging, and available resources to build out workflows.

Learning Objectives:
Participants will demonstrate correct LA ARV injection technique for cabotegravir and lenacapavir. Attendees will leave with reviewed publicly-available resources for hands-on training replication. Clinic staff will identify actionable workflows adaptable to their own settings for LA ARV implementation, including insurance, scheduling, and patient communication protocols.

Track 7

Testing for Everyone: Reaching Every Age, Every Community, Every Opportunity

Presenter:
M. Keith Rawlings, MD, Chair, HIV Section, National Medical Association; Nada Fadul, MD; Tamara McCants, PharmD

Workshops Session 8

Sunday, September 20 · 9:00 am – 10:30 am

Location: Manhatten – Concourse Level/4th Floor

The importance of expanding HIV testing.

Learning Objectives:
Increase awareness of limited HIV testing; implications of recent policies affecting HIV testing in Ending the Epidemic jurisdictions.

No sessions match the selected filters.

Clear Filters

Please Note: This information represents only a portion of the full conference program.

For a complete listing of all Workshops, iPosters, and Institutes, please refer to the 2026 USCHA conference app that will be available in the coming weeks.


Nota: Esta información representa solo una parte del programa completo de la conferencia.

Para consultar la lista completa de todos los talleres, pósteres digitales e institutos, remítase a la aplicación de la conferencia USCHA 2026, que estará disponible en las próximas semanas.

2026 U.S.C.H.A. 45 Years of the H.I.V. Movement

Contact

For information, updates, and questions about NMAC’s 2026 US Conference on HIV/AIDS, please email conferences@nmac.org.

United and Unbreakable